CompaniesByCap
AMRX
Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ · Healthcare

Amneal Pharmaceuticals Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue3.02B2.79B2.39B2.21B2.09B1.99B1.63B1.66B1.03B1.02B
Gross Profit1.11B1.02B820.6M784.7M769.0M628.4M353.0M716.4M526.2M597.5M
Profitability
Operating Income394.1M249.3M204.4M-94.9M152.7M91.2M-248.7M-19.7M245.1M284.9M
EBITDA
Net Income72.1M-116.9M-84.0M-270.6M13.2M67.8M-603.6M-19.7M00
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)325M309M176M151M152M149M132M127M0M

Amneal Pharmaceuticals Inc. Income Statement — FAQ

Amneal Pharmaceuticals Inc. (AMRX) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AMRX's income statement history?

The chart and table above show Amneal Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.